AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.42 billion. The enterprise value is $3.68 billion.
| Market Cap | 1.42B |
| Enterprise Value | 3.68B |
Important Dates
The next confirmed earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 133.20 million shares outstanding. The number of shares has decreased by -2.25% in one year.
| Shares Outstanding | 133.20M |
| Shares Change (YoY) | -2.25% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 11.89% |
| Owned by Institutions (%) | 87.67% |
| Float | 72.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.59 |
| PS Ratio | 0.44 |
| Forward PS | 0.41 |
| PB Ratio | 0.97 |
| P/FCF Ratio | 26.63 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 69.20 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.60.
| Current Ratio | 1.33 |
| Quick Ratio | 1.03 |
| Debt / Equity | 1.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | 44.07 |
| Interest Coverage | -4.64 |
Financial Efficiency
Return on equity (ROE) is -40.80% and return on invested capital (ROIC) is -15.08%.
| Return on Equity (ROE) | -40.80% |
| Return on Assets (ROA) | -14.70% |
| Return on Capital (ROIC) | -15.08% |
| Revenue Per Employee | $303,556 |
| Profits Per Employee | -$65,116 |
| Employee Count | 10,700 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 22.41 |
Taxes
| Income Tax | -40.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.80% in the last 52 weeks. The beta is 1.12, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -25.80% |
| 50-Day Moving Average | 10.24 |
| 200-Day Moving Average | 8.95 |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 1,112,089 |
Short Selling Information
The latest short interest is 8.55 million, so 6.42% of the outstanding shares have been sold short.
| Short Interest | 8.55M |
| Short Previous Month | 8.10M |
| Short % of Shares Out | 6.42% |
| Short % of Float | 11.80% |
| Short Ratio (days to cover) | 7.30 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.25 billion and -$696.74 million in losses. Loss per share was -$5.30.
| Revenue | 3.25B |
| Gross Profit | 507.14M |
| Operating Income | -574.05M |
| Pretax Income | -737.42M |
| Net Income | -696.74M |
| EBITDA | -182.87M |
| EBIT | -606.60M |
| Loss Per Share | -$5.30 |
Balance Sheet
The company has $79.57 million in cash and $2.35 billion in debt, giving a net cash position of -$2.27 billion or -$17.01 per share.
| Cash & Cash Equivalents | 79.57M |
| Total Debt | 2.35B |
| Net Cash | -2.27B |
| Net Cash Per Share | -$17.01 |
| Equity (Book Value) | 1.46B |
| Book Value Per Share | 10.97 |
| Working Capital | 163.29M |
Cash Flow
In the last 12 months, operating cash flow was $389.45 million and capital expenditures -$336.23 million, giving a free cash flow of $53.22 million.
| Operating Cash Flow | 389.45M |
| Capital Expenditures | -336.23M |
| Free Cash Flow | 53.22M |
| FCF Per Share | $0.40 |
Margins
Gross margin is 15.61%, with operating and profit margins of -17.67% and -21.45%.
| Gross Margin | 15.61% |
| Operating Margin | -17.67% |
| Pretax Margin | -22.70% |
| Profit Margin | -21.45% |
| EBITDA Margin | -5.63% |
| EBIT Margin | -18.68% |
| FCF Margin | 1.64% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.25% |
| Shareholder Yield | 2.25% |
| Earnings Yield | -49.16% |
| FCF Yield | 3.76% |
Analyst Forecast
The average price target for AdaptHealth is $12.92, which is 21.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.92 |
| Price Target Difference | 21.43% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 0.4 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.4 |
| Piotroski F-Score | 7 |